Expert support for developing new neurological treatments
BIOLOGICS SME CONSULTING SERVICES
This study is looking for expert advice to help create better medicines for neurological disorders, so patients can have more effective treatment options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project ID | NIH-11219439 on NIH RePORTER |
What this research studies
This research focuses on obtaining expert guidance to enhance the development of biologics and biopharmaceuticals aimed at treating neurological disorders. By leveraging specialized knowledge, the project aims to streamline the process of bringing new therapeutic agents from concept to clinical use. Patients may benefit from improved treatment options as a result of more effective product development strategies employed by the National Institute of Neurological Disorders and Stroke (NINDS).
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit are individuals with neurological disorders who may be treated with new biologic therapies.
Not a fit: Patients with conditions unrelated to neurological disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for neurological conditions.
How similar studies have performed: Previous research has shown that expert consulting in product development can significantly enhance the success rates of new therapeutic agents.
Where this research is happening
Clifton, United States
Researchers
- Principal investigator: Mishra, Somnath
- Study coordinator: Mishra, Somnath
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.